Samumed At Forbes Healthcare Summit

[Noisette]

The World’s Most Influential Healthcare Event
Solving Healthcare’s Biggest Challenges
November 30-December 1, 2016 | New York City​

Speaker: Osman Kibar

Maybe, we can have the results of the phase 2 SM04554

 

[Follisket]

His hair sure ain't reassuring.

 

[hellouser]

His hair sure ain't reassuring.

Neither is Cotsarelis' or Dr. Lauster's....

 

[Swoop]

Neither is Cotsarelis' or Dr. Lauster's....

Haven't heard from Lauster from a while.. What is he doing currently?

 

[hellouser]

Haven't heard from Lauster from a while.. What is he doing currently?

Your guess is as good as mine, all we know is what we heard from them last year from my interview with Beren Atac and Gerd Lindner...

 

[Pavi]

I don't get why they got through 2 phases in an instant and then phase 3 rolls around and they're hesitant

 

[hellouser]

I don't get why they got through 2 phases in an instant and then phase 3 rolls around and they're hesitant

FDA. You can thank them for choking progress.

 

[hellouser]

some months ago i read in the german alopecia forum that one member received an answer via mail from dr. lindner.
it says they are practically done and don't have enough funding, thus won't continue with the research.
not sure if it's true but i wouldn't be surprised at all. they didn't succeed with the DP culturing problem. however dr. beren atac or others from the team might still attend the next hair congress and give some presentation, probably to create some interest and maybe funding.

meanwhile lauster's team was even beaten with the whole organ on a chip concept.
other companies and universities already presented more advanced of such chip organ platforms in the recent years.

so my guess is they are game over with hair loss research and organ on a chip platforms. that beeing said, i mean they seem to have no serious interest to bring the stuff to market. but because they are a university i assume they will still tinker around a bit with these topics unless they find a new promising research topic.

I might reach out to Beren and Gerd before the end of the year, see if they can give us a small update via email.